Advanced search
Publication Cover
HIV Clinical Trials Volume 17, 2016 - Issue 3
Submit an article Journal homepage
276
Views
0
CrossRef citations to date
0
Altmetric
Articles

Fosamprenavir/ritonavir in patients with viral hepatitis coinfection: an observational multicohort study

Paola NastaUniversity Division of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Spedali Civili Hospital, Brescia, ItalyCorrespondence[email protected]
,
Dominique SalmonService des Maladies Infectieuses et Tropicales, Hôpital Cochin, APHP-Université Paris Descartes, Paris, France
,
Antonella d’Arminio MonforteInfectious Diseases Unit, Department of Health Sciences, ASST Santi Paolo e Carlo University Hospital, Milan, Italy
,
Jeanne M. PimentaWorldwide Epidemiology, GlaxoSmithKline, Stockley Park, UK
,
Carlo CeriniUniversity Division of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Spedali Civili Hospital, Brescia, Italy
,
Mariarosaria GiraldaUniversity Division of Infectious and Tropical Diseases, University of Brescia and Spedali Civili General Hospital, Spedali Civili Hospital, Brescia, Italy
,
Maria WinnockISPED, Université Bordeaux, F33000Bordeaux, France;INSERM, Centre INSERM U897, Bordeaux, France
&
Alessandro Cozzi-LepriResearch Department of Infection and Population Health, University College London, London, UK
 show all
Pages 96-108 | Published online: 16 Mar 2016

References

  • Soriano V, Vispo E, Labarga P, Medrano J, Barreiro P. Viral hepatitis and HIV co-infection. Antiviral Res. 2010;85:303–315.10.1016/j.antiviral.2009.10.021
  • Puoti M, Moioli MC, Travi G, Rossotti R. The burden of liver disease in human immunodeficiency virus-infected patients. Semin Liver Dis. 2012;32:103–113.
  • Salmon-Ceron D, Rosenthal E, Lewden C, et al. Emerging role of hepatocellular carcinoma among liver-related causes of deaths in HIV-infected patients: The French national Mortalité 2005 study. J Hepatol. 2009;50:736–745.10.1016/j.jhep.2008.11.018
  • Soriano V, Puoti M, Garcia-Gasco P, et al. Antiretroviral drugs and liver injury. AIDS. 2008;22:1–13.10.1097/QAD.0b013e3282f0e2fd
  • Nasta P, Cattelan I, Maida F, Chiari E, Puoti MC. Antiretroviral therapy in HIV/HCV Co-infection Italian consensus workshop. Adv Infect Dis. 2013;03:105–114.10.4236/aid.2013.32017
  • Wire MB, Shelton MJ, Studenberg S. Fosamprenavir. Clin Pharmacokinet. 2006;45:137–168.10.2165/00003088-200645020-00002
  • Gatti F, Nasta P, Loregian A, et al. Unboosted fosamprenavir is associated with low drug exposure in HIV-infected patients with mild-moderate liver impairment resulting from HCV-related cirrhosis. J Antimicrob Chemother. 2009;63:575–578.10.1093/jac/dkn525
  • Regazzi M, Villani P, Gulminetti R, et al. Therapeutic monitoring and variability of atazanavir in HIV-infected patients, with and without HCV Coinfection, receiving boosted or unboosted regimens. Ther Drug Monit. 2011;33:303–308.10.1097/FTD.0b013e31821c2772
  • Perez-Elias MJ, Morellon ML, Ortega E, et al. Pharmacokinetics of fosamprenavir plus ritonavir in human immunodeficiency virus type 1-infected adult subjects with hepatic impairment. Antimicrob Agents Chemother. 2009;53:5185–5196.10.1128/AAC.00632-09
  • d’Arminio Monforte A, Cozzi-Lepri A, Girardi E, et al. Late presenters in new HIV diagnoses from an Italian cohort of HIV-infected patients: prevalence and clinical outcome. Antivir Ther 2011; 16: 1103–1112.10.3851/IMP1883
  • Torti C, Lapadula G, Maggiolo F, et al. Predictors of AIDS-defining events among advanced naïve patients after HAART. HIV Clin Trials. 2007;8:112–120.10.1310/hct0803-112
  • Loko MA, Salmon D, Carrieri P, et al. The French national prospective cohort of patients co-infected with HIV and HCV (ANRS CO13 HEPAVIH): Early findings, 2006–2010. BMC Infect Dis. 2010;10:303.10.1186/1471-2334-10-303
  • Castera L, Vergniol J, Foucher J, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology. 2005;128:343–350.10.1053/j.gastro.2004.11.018
  • Vallet-Pichard A, Mallet V, Nalpas B, et al. FIB-4: An inexpensive and accurate marker of fibrosis in HCV infection. Comparison with liver biopsy and fibrotest. Hepatology. 2007;46:32–36.10.1002/(ISSN)1527-3350
  • Pugh RN, Murray-Lyon IM, Dawson JL, Pietroni MC, Williams R. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg. 1973;60:646–649.10.1002/(ISSN)1365-2168

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.